Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100000130
HKD
2.36
-0.06 (-2.48%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
978.10
955.37
929.91
978.66
850.22
699.22
732.38
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
978.10
955.37
929.91
978.66
850.22
699.22
732.38
Raw Material Cost
156.39
212.41
284.54
225.08
151.19
102.83
121.93
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
240.91
117.68
112.59
170.28
142.24
152.22
251.94
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.50
2.20
0.57
0.55
0.41
0.80
0.14
Selling and Distribution Expenses
575.58
518.51
481.62
570.84
524.20
444.04
441.41
Other Expenses
-20.92
-7.17
-9.87
-14.87
-11.79
-11.57
-23.89
Total Expenditure (Excl Depreciation)
765.19
779.07
780.63
818.08
700.20
584.17
576.53
Operating Profit (PBDIT) excl Other Income
212.89999999999998
176.29999999999998
149.3
160.6
150
115
155.9
Other Income
73.51
44.22
70.78
82.34
59.96
52.79
41.55
Operating Profit (PBDIT)
317.15
249.95
250.51
281.99
246.62
193.84
223.08
Interest
1.50
2.20
0.57
0.55
0.41
0.80
0.14
Exceptional Items
1.90
6.28
-0.35
-12.87
2.25
0.47
0.00
Gross Profit (PBDT)
821.71
742.96
645.37
753.59
699.03
596.39
610.45
Depreciation
30.73
29.43
30.45
39.08
34.80
24.90
24.18
Profit Before Tax
286.82
224.61
219.14
229.49
213.65
168.60
198.77
Tax
71.12
24.84
55.37
4.40
40.97
26.39
34.66
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
215.69
199.77
163.77
225.09
172.69
142.21
164.11
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
215.69
199.77
163.77
225.09
172.69
142.21
164.11
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
215.69
199.77
163.77
225.09
172.69
142.21
164.11
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.11
0.11
0.11
0.11
0.12
0.12
0.11
Reserves
1,880.60
1,734.25
1,629.91
1,810.19
1,778.32
1,595.26
1,385.42
Earnings per share (EPS)
0.39
0.36
0.29
0.4
0.31
0.25
0.29
Diluted Earnings per share
0.39
0.36
0.29
0.4
0.31
0.25
0.29
Operating Profit Margin (Excl OI)
21.77%
18.45%
16.05%
16.41%
17.86%
16.61%
21.48%
Gross Profit Margin
32.47%
26.59%
26.84%
27.44%
29.22%
27.67%
30.44%
PAT Margin
22.05%
20.91%
17.61%
23.0%
20.31%
20.34%
22.41%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is 2.38% vs 2.74% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2025 is 7.96% vs 21.98% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is 18.42% vs 14.47% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is -31.82% vs 266.67% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2025 has improved from Dec 2024

Compare Annual Results Of Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(HKD)
Change(%)
Net Sales
978.10
91.89
886.21
964.42%
Other Operating Income
0.00
0.00
0.00
Total Operating income
978.10
91.89
886.21
964.42%
Raw Material Cost
156.39
31.60
124.79
394.91%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
240.91
31.04
209.87
676.13%
Power Cost
0
0
0.00
Manufacturing Expenses
1.50
18.55
-17.05
-91.91%
Selling and Distribution Expenses
575.58
82.53
493.05
597.42%
Other Expenses
-20.92
-4.96
-15.96
-321.77%
Total Expenditure (Excl Depreciation)
765.19
114.13
651.06
570.45%
Operating Profit (PBDIT) excl Other Income
212.90
-22.24
235.14
1,057.28%
Other Income
73.51
2.63
70.88
2,695.06%
Operating Profit (PBDIT)
317.15
-5.40
322.55
5,973.15%
Interest
1.50
18.55
-17.05
-91.91%
Exceptional Items
1.90
-11.16
13.06
117.03%
Gross Profit (PBDT)
821.71
60.28
761.43
1,263.16%
Depreciation
30.73
14.21
16.52
116.26%
Profit Before Tax
286.82
-49.33
336.15
681.43%
Tax
71.12
0.09
71.03
78,922.22%
Provisions and contingencies
0
0
0.00
Profit After Tax
215.69
-49.36
265.05
536.97%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
215.69
-49.36
265.05
536.97%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
-0.06
0.06
100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
215.69
-49.42
265.11
536.44%
Equity Capital
0
0
0.00
Face Value
0.11
0.10
0.00
Reserves
1,880.60
155.28
1,725.32
1,111.10%
Earnings per share (EPS)
0.39
-0.05
0.44
880.00%
Diluted Earnings per share
0.39
-0.05
0.44
880.00%
Operating Profit Margin (Excl OI)
21.77%
-24.21%
0.00
45.98%
Gross Profit Margin
32.47%
-38.22%
0.00
70.69%
PAT Margin
22.05%
-53.72%
0.00
75.77%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 97.81 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 2.38% vs 2.74% in Dec 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 21.57 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 7.96% vs 21.98% in Dec 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 24.36 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 18.42% vs 14.47% in Dec 2024

Annual - Interest
Interest 0.15 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -31.82% vs 266.67% in Dec 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 21.77%
in Dec 2025

Figures in %
stock-summary

YoY Growth in year ended Dec 2025 has improved from Dec 2024